Immunocytochemical localization of oncodevelopmental proteins in human germ cell and hepatic tumors.
In a combined tissue and serum study alpha-1-antitrypsin (AAT) and alpha-fetoprotein are demonstrated in parallel within tumor tissue inclusions in both endodermal sinus (yolk sac) tumors and malignant hepatomas, and AAT is demonstrated as a marker in both neoplastic and preneoplastic liver lesions occurring in oral contraceptive users, all in association with normal serum AAT phenotype. The tumor inclusions in the first two instances differ immunocytochemically from AAT liver cell globules found in inherited AAT deficiency, which are unreactive for alpha-fetoprotein. It is concluded that unlike the molecular basis of storage associated with AAT phenotypic variation, the tumor inclusions reflect a separate, nongenetic mechanism of AAT storage, which may be epigenetic in nature. AAT and alpha-fetoprotein both are synthesized normally in yolk sac and fetal liver, a parallelism which disappears soon after birth. The reexpression of both proteins in two distinct tumor types arising from endodermal origins (yolk sac and liver), suggests that these markers may represent reemerging fetal gene products, a phenomenon previously proposed only for alpha-fetoprotein, a prototypic "oncofetal antigen."
D003276:Contraceptives, Oral / Q000009:adverse effects; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000209:etiology; D008297:Male; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D013736:Testicular Neoplasms / Q000175:diagnosis*; D000515:alpha 1-Antitrypsin; D000509:alpha-Fetoproteins
D003276:Contraceptives, Oral; D000515:alpha 1-Antitrypsin; D000509:alpha-Fetoproteins